Immunovant, Inc. (IMVT)
- Previous Close
15.22 - Open
15.05 - Bid 10.70 x 200
- Ask 17.72 x 200
- Day's Range
13.77 - 15.46 - 52 Week Range
12.72 - 34.47 - Volume
1,131,795 - Avg. Volume
1,777,995 - Market Cap (intraday)
2.344B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
-- - EPS (TTM)
-2.62 - Earnings Date May 30, 2025 - Jun 6, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
45.15
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
immunovant.comRecent News: IMVT
View More
Performance Overview: IMVT
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMVT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMVT
View MoreValuation Measures
Market Cap
2.59B
Enterprise Value
2.21B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
7.33
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-44.73%
Return on Equity (ttm)
-74.17%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-382.71M
Diluted EPS (ttm)
-2.62
Balance Sheet and Cash Flow
Total Cash (mrq)
374.68M
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
-187.67M
Research Analysis: IMVT
View MoreResearch Reports: IMVT
View MoreDaily – Vickers Top Buyers & Sellers for 04/14/2025
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 07/11/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/22/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/30/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.